Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2018-10-16 | 2018-10-16 |
| Drug Identification Number | 00260428 | 00260428 |
| Brand name | DEPO-MEDROL WITH LIDOCAINE | DEPO-MEDROL WITH LIDOCAINE |
| Common or Proper name | Depo-Medrol + Lidocaine | Depo-Medrol + Lidocaine |
| Company Name | PFIZER CANADA ULC | PFIZER CANADA ULC |
| Ingredients | LIDOCAINE HYDROCHLORIDE METHYLPREDNISOLONE ACETATE | LIDOCAINE HYDROCHLORIDE METHYLPREDNISOLONE ACETATE |
| Strength(s) | 10MG 40MG | 10MG 40MG |
| Dosage form(s) | SUSPENSION | SUSPENSION |
| Route of administration | INTRA-ARTICULAR INTRABURSAL | INTRA-ARTICULAR INTRABURSAL |
| Packaging size | 1x1ml | 1x1ml |
| ATC code | H02BX | H02BX |
| ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS | CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS |
| Reason for discontinuation | Business reasons | Business reasons |
| Anticipated discontinuation date | ||
| Actual discontinuation date | 2018-10-15 | 2018-10-15 |
| Remaining supply date | 2018-10-15 | 2018-10-15 |
| Discontinuation status | Discontinued | Discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | Format replaced by Depo-Medrol+Lidocaine 40mg/ml 1x2ml. | Format replaced by Depo-Medrol+Lidocaine 40mg/ml 1x2ml. |
| Health Canada comments |